Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis
Gelissen, L. M. Y.,
Toorop, A. A., Schipper, P. M., Hoitsma, E., Zeinstra, E. M. P. E., van Rooij, L. C.,
van Munster, C. E. P.,
Vennegoor, A., Mostert, J., Wokke, B.,
Kalkers, N. F.,
Hoogervorst, E. L. J.,
van Eijk, J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J.,
Nielsen, J., Sinnige, L. G. F. & Kloosterziel, M. E.
& 11 others,
Arnoldus, E. P. J., Bouvy, W. H., Strijbis, E. M., Oosten, B. V., De Jong, B. A., Uitdehaag, B. M. J., Lissenberg-Witte, B. I., Loeff, F. C., Rispens, T., Killestein, J. & van Kempen, Z. L. E.,
25 Mar 2025, (E-pub ahead of print)
In: Journal of neurology, neurosurgery, and psychiatry.Research output: Contribution to journal › Article › Academic › peer-review
